These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Single Cell Killing Kinetics Differentiate Phenotypic Bacterial Responses to Different Antibacterial Classes. Zhang Y; Kepiro I; Ryadnov MG; Pagliara S Microbiol Spectr; 2023 Feb; 11(1):e0366722. PubMed ID: 36651776 [TBL] [Abstract][Full Text] [Related]
5. p-Coumaric acid inhibits the Listeria monocytogenes RecA protein functions and SOS response: An antimicrobial target. Ojha D; Patil KN Biochem Biophys Res Commun; 2019 Oct; 517(4):655-661. PubMed ID: 31416617 [TBL] [Abstract][Full Text] [Related]
6. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients. Sanchez GV; Baird AM; Karlowsky JA; Master RN; Bordon JM J Antimicrob Chemother; 2014 Dec; 69(12):3259-62. PubMed ID: 25063776 [TBL] [Abstract][Full Text] [Related]
7. Resensitizing tigecycline- and colistin-resistant Zhang H; Chen B; Wang Z; Peng K; Liu Y; Wang Z Microbiol Spectr; 2024 Apr; 12(4):e0388423. PubMed ID: 38385691 [TBL] [Abstract][Full Text] [Related]
8. The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011. Zykov IN; Sundsfjord A; Småbrekke L; Samuelsen Ø Infect Dis (Lond); 2016 Feb; 48(2):99-107. PubMed ID: 26414659 [TBL] [Abstract][Full Text] [Related]
9. Antibiotic Resistance of Bacteria Involved in Urinary Infections in Brazil: A Cross-Sectional and Retrospective Study. Rodrigues WF; Miguel CB; Nogueira AP; Ueira-Vieira C; Paulino Tde P; Soares Sde C; De Resende EA; Lazo-Chica JE; Araújo MC; Oliveira CJ Int J Environ Res Public Health; 2016 Sep; 13(9):. PubMed ID: 27649224 [TBL] [Abstract][Full Text] [Related]
10. High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City. Arredondo-García JL; Amábile-Cuevas CF J Infect Dev Ctries; 2008 Oct; 2(5):350-3. PubMed ID: 19745501 [TBL] [Abstract][Full Text] [Related]
11. RadD Contributes to R-Loop Avoidance in Sub-MIC Tobramycin. Negro V; Krin E; Aguilar Pierlé S; Chaze T; Giai Gianetto Q; Kennedy SP; Matondo M; Mazel D; Baharoglu Z mBio; 2019 Jul; 10(4):. PubMed ID: 31266870 [TBL] [Abstract][Full Text] [Related]
13. Quinolone Resistance Reversion by Targeting the SOS Response. Recacha E; Machuca J; Díaz de Alba P; Ramos-Güelfo M; Docobo-Pérez F; Rodriguez-Beltrán J; Blázquez J; Pascual A; Rodríguez-Martínez JM mBio; 2017 Oct; 8(5):. PubMed ID: 29018116 [TBL] [Abstract][Full Text] [Related]
14. Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli. López E; Blázquez J Antimicrob Agents Chemother; 2009 Aug; 53(8):3411-5. PubMed ID: 19487441 [TBL] [Abstract][Full Text] [Related]
15. Analysis of RuvABC and RecG involvement in the escherichia coli response to the covalent topoisomerase-DNA complex. Sutherland JH; Tse-Dinh YC J Bacteriol; 2010 Sep; 192(17):4445-51. PubMed ID: 20601468 [TBL] [Abstract][Full Text] [Related]
16. Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012. Sanchez GV; Babiker A; Master RN; Luu T; Mathur A; Bordon J Antimicrob Agents Chemother; 2016 May; 60(5):2680-3. PubMed ID: 26883714 [TBL] [Abstract][Full Text] [Related]
17. Trends, seasonality and the association between outpatient antibiotic use and antimicrobial resistance among urinary bacteria in the Netherlands. Martínez EP; van Rosmalen J; Bustillos R; Natsch S; Mouton JW; Verbon A J Antimicrob Chemother; 2020 Aug; 75(8):2314-2325. PubMed ID: 32417922 [TBL] [Abstract][Full Text] [Related]
18. Exposure to sub-inhibitory ciprofloxacin and nitrofurantoin concentrations increases recA gene expression in uropathogenic Escherichia coli: The role of RecA protein as a drug target. Ribeiro ÁCDS; Martins WMBDS; Silva AAD; Gales AC; Rando DGG; Minarini LADR Eur J Pharm Sci; 2020 Apr; 146():105268. PubMed ID: 32081832 [TBL] [Abstract][Full Text] [Related]
19. Highly Contingent Phenotypes of Lon Protease Deficiency in Escherichia coli upon Antibiotic Challenge. Matange N J Bacteriol; 2020 Jan; 202(3):. PubMed ID: 31740490 [TBL] [Abstract][Full Text] [Related]